智合规丨医药行业模块 (威科先行 AI+ 中国法律)
威科先行® 智·合规丨医药行业是一款基于威科先行 AI+ 中国法律推出的聚焦于医药行业、高度贴合医药行业法律合规需求的专家解决方案。针对医药企业、医疗器械企业与医疗机构三大主体，覆盖医药健康行业，集合法规与案例查询、实务问题解决、深入专家解读、在线专家问答等功能，助力医药行业企业专业合规，自信应对经营风险。
客戶如需加訂閱 add-on 模块，須同時訂閱主數據庫 <威科先行 AI+ 中国法律> 才能配合这个模块一起使用, 信息库有两个不同版本可供选择:
- 中文专业版
- 双语专业版
(不同版本包含不同内容, 请按此比较内容区别)
免费试用, 请发请求到 [email protected]
*** 请输入优惠码 “CHINALAW1015" 享受优惠折扣 ***
医药行业一站式合规解决方案
- 行业聚焦，全新界面，体验更流畅更优质
- 针对医药行业不同企业类型提供精准信息，更深入更高效
- 覆盖企业生命全流程的信息指引，更清晰更完整
- 涵盖许可准入、合规管理、投资经营各发展阶段和方向的合规需求，更前沿更实操
- 权威医药行业法律合规专家保驾护航，更专业更自信
优势功能与内容，您的医药行业合规专家
- 包含海量信息，全方位功能与栏目强强联合
- 囊括15 项优势栏目功能，更智能更丰富：
- 海量法规精中选精、及时更新、高效检索、智能关联、批量下载；
- 飞行检查文书、行政处罚、裁判文书、典型案例等多种官方案例资源，助您掌握监管口径与动向；
- 集合业内专家及时、深入解读的专业文章，成体系剖析实务问题的专题聚焦，大体量高价值的实务指南，层层递进为您的实务操作保驾护航；
- 更有多种形式的工具助手（智能图表、智能决策、内训助手）助力您的效率提升；
- 实时更新的行业动态，帮您把握前沿态势、洞悉行业发展。
实操报告兼具体系化与实操性，解决实务痛点，提供合规指引
独特的智能风险筛查工具，以清晰易用的图表形式梳理展现，汇聚多维度相关信息，便捷、高效医药行业行政处罚风险提示与防范解析智能图表
内容介绍：
本智能图表提供医药行业行政处罚事项的梳理内容，针对医药企业( 含MAH、CRO、CMO、CDMO、CSO)、医疗器械企业( 含MAH、CRO、CMO、CDMO、CSO) 及医疗机构三类主体，分别提示风险行为、梳理处罚依据、处罚内容及参考案例，并邀请专业律师撰写防范解析，助力您实现高效合规。
药品监督管理局行政许可事项清单智能图表
内容介绍：
本智能图表提供药品监督管理局行政许可事项的梳理内容，涵盖药品、医疗器械、医疗机构( 含从业人员) 主题下的许可事项，覆盖重点地域级别，提供行政许可事项的信息及办事指南，用户可根据查询需要，定位主题和目标地域/ 级别后选择事项类别快速查找。
威科先行·AI+ 中国法律
威科先行 AI+ 中国法律 是威科集团依托丰富的全球服务经验，为法律专业人士提供的整体信息解决方案。该数据库以卓越的技术实力，联合资深专家团队打造，集法规、案例、解读、工具、问答、法律速递、实务模块等为一体, 为您精准决策、高效工作提供强大支持。
小威AI+: (AI 功能示范):
法律检索: (功能示范):
Add-on Module: Pharmaceuticals industrial compliance (Wolters Kluwer AI+ China Law)
Smart Compliance for Pharmaceutical Industry is launched by Wolters Kluwer Legal Information Database to provide targeted compliance solutions for the pharmaceutical industry. The product aims to serve pharmaceutical companies, medical device makers and medical institutions, and offers functions like access to laws, regulations and cases, addressing legal practical problems, providing expert explanations and online Q&As, to help companies do business in compliance with related regulations and deal with operational risks.
Customers who wish to subscribe to the add-on modules must also subscribe to the main database 'Wolters Kluwer AI+ China Law' to access the content. The main database is available in two versions:
- Chinese Professional Version
- Bilingual Professional Version
(The different versions include varying content., please click here to compare the differences)
Get a FREE trial, send request to [email protected]
*** Please enter discount code “CHINALAW1015" to enjoy special discount ***
One-stop compliance solution for the pharmaceutical industry
- Industry focus, all-new interface, and better experience Provide targeted information according to different types of companies in the pharmaceutical industry, information service is more profound and efficient.
- Cover more clear and integral information guidelines in the whole life of an enterprise
- Cover compliance requirements on licensing & access, compliance management and at different development stages and directions of business operation and investment
- With instructions from our legal team with expertise in services to the pharmaceutical industry, you can deal with compliance issues more professionally and confidently
All-round functions and resourceful content, your adviser in pharmaceutical business compliance
Abundant information, all-round functions and columns
15 columns and functions offer smart services and resourceful content:
- Select useful information and quickly search information you need, timely update, smart link, bulk download;
- Unannounced inspection letters, letters of administrative punishment, ruling papers, typical cases and other official documents are provided to help you grasp regulatory criteria and trends;
- We collect profound and professional articles from industry experts to make systematic analysis of practical issues and provide valuable practice guide;
- We provide various tools (smart diagrams, smart decision-making and internal training assistant) to help you improve work efficiency;
- Our up-to-date industry news can help you grasp the development trend of the industry.
Our solutions target your biggest concerns and address your most-urgent problems
- Summarize key compliance issues in the business processes of pharmaceutical enterprises, medical device enterprises and medical institutions, make in-depth discussions of hot issues and facilitate sound closed-loop compliance management.
- Our compliance practice assistants for anti-commercial bribery, third party management and advertising include some valuable resources like practice report, template report on internal training and hot issue discussion, to provide onestop compliance solutions.
The practice report can address your pain points and offer compliance guidelines
Our smart risk screening tool can present diagrams in an easy and straightforward manner to display multidimensional information and make your compliance work more convenient and efficient Smart diagrams on risk warning and prevention of administrative punishment in the pharmaceutical industry
Content introduction:
The smart diagrams can remind pharmaceutical enterprises (Including MAH, CRO, CMO, CDMO and CSO), medical device enterprises (Including MAH, CRO, CMO, CDMO and CSO) and medical institutions of their risk behaviors, punishment reasons, punishment details and reference cases. We also invite professional lawyers to explain how to avoid administrative punishments and help you meet compliance requirements.
Smart diagrams on a list of administrative licensing matters to be approved by the drug administration
Content introduction:
The smart diagrams cover administrative licensing matters related to drugs, medical devices and medical institutions (Including medical personnel), and provide information about how to handle these administrative licensing matters at key jurisdictions. Users can pinpoint theme and target jurisdiction to select a type of administrative licensing matter and find related information.
